Northeast Pharmaceutical discloses related-party transactions for 2025, mainly consisting of operational exchanges.

Zhongfang Network data

Northeast Pharmaceutical Group Co., Ltd. recently disclosed its 2025 summary table of non-operating funds occupied and other related-party capital transactions. The announcement shows that, during the reporting period, the company had no instances of non-operating funds occupied by its controlling shareholder(s), actual controller(s), or their affiliated enterprises. In terms of other related-party capital transactions, the company has frequent business cooperation with many related parties, mainly reflected in operating transactions such as selling goods and paying deposits and warranty deposits.

Key figures show that in 2025, the cumulative amount of funds exchanged between the company and related parties (excluding interest) totaled approximately RMB 279.1442 million, and the balance of outstanding funds at the end of the reporting period was RMB 107.8045 million. The counterparties mainly include the Third Affiliated Hospital of Chongqing Medical University (Fangda Hospital), Liaoning Fangda General Hospital Co., Ltd., Northern Heavy Industry Group Co., Ltd., and others that are jointly controlled by the ultimate controlling party, as well as certain controlled companies held by minority shareholders of some subsidiary companies, such as Jinzhou Liaoxi Sinopharm Chain Co., Ltd. The accounting items involved in the fund transactions mainly include accounts receivable, contract assets, and other receivables.

From the specific data, the company has a relatively large scale of accounts-receivable transactions with Liaoning Fangda General Hospital Co., Ltd.: opening balance of RMB 19.7118 million, current-period amount of RMB 37.7160 million, and closing balance of RMB 25.3131 million. Accounts-receivable transactions with the Tiexan Branch of Shenyang Fangda Real Estate Development Co., Ltd. are also significant, with the current-period amount reaching RMB 265.2169 million. Overall, all disclosed related-party funds transactions are categorized as “operating transactions,” reflecting the company’s funds settlement relationship with related parties arising from normal business activities. This disclosure complies with the requirements for standardized operations of listed companies and demonstrates transparent management of its related-party transactions.

Endless information, precise interpretation—available in the Sina Finance app